Pfizer Inc.
New York, NY 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
- $170M
- 17 holdings
- 2026 Q2
- −28.9% QoQ
- Top 5 78.9%
Pfizer's biggest moves in 2026 Q2 were trimming Oric Pharmaceuticals and Zura Bio, and selling out of Q32 Bio.
AUM over time
Latest book
| ALLO, Allogene Therapeutics | Hold | 22,032,040 | $2.13 | $47M | — | — | |
| CELC, Celcuity | Hold | 295,652 | $99.95 | $30M | — | — | |
| ARVN, Arvinas | Hold | 3,457,815 | $8.00 | $28M | — | — | |
| PYXS, Pyxis Oncology | Hold | 7,032,770 | $2.77 | $19M | — | — | |
| WVE, Wave Life Sciences | Hold | 1,875,000 | $5.83 | $11M | — | — | |
| BHVN, Biohaven | Hold | 505,645 | $15.83 | $8M | — | — | |
| CRBU, Caribou Biosciences | Hold | 4,690,431 | $1.68 | $7.9M | — | — | |
| Spero Therapeutics | Hold | 2,362,348 | $2.26 | $5.3M | — | — | |
| ZNTL, Zentalis Pharmaceuticals | Hold | 953,834 | $4.04 | $3.9M | — | — | |
| ORIC, Oric Pharmaceuticals | Reduce −92.2% | 372,904 | $9.53 | $3.6M | −4,407,497 | −$54M | |
| CRDF, Cardiff Oncology | Hold | 2,411,575 | $1.25 | $3M | — | — | |
| ZURA, Zura Bio | Reduce −81.0% | 538,841 | $5.35 | $2.9M | −2,300,072 | −$14M | |
| AGMB, Agomab Therapeutics | Hold | 75,000 | $13.81 | $1M | — | — | |
| BOLT, Bolt Biotherapeutics | Hold | 31,305 | $4.28 | $134K | — | — | |
| NXTC, Nextcure | Reduce −71.1% | 44,347 | $1.65 | $73K | −109,007 | −$1.5M | |
| DNA, Ginkgo Bioworks | Hold | 2,928 | $10.25 | $30K | — | — | |
| Senseonics | Hold | 2,171 | $5.72 | $12K | — | — |
Exits / last held
Gone since 2026 Q1, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| QTTB, Q32 Bio | Exit | 0 | $7.25 | $737K | −101,618 | −$737K |
Filings history
4 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 17 | $170M | −28.9% | 13F-HR | 8/13/2026 | 000007800326000102 |
| 2026 Q1 | 18 | $239M | +1.3% | 13F-HR | 5/12/2026 | 000007800326000064 |
| 2025 Q4 | 18 | $236M | −46.0% | 13F-HR | 2/12/2026 | 000007800326000013 |
| 2025 Q3 | 21 | $437M | — | 13F-HR | 11/13/2025 | 000007800325000161 |
About
Pfizer Inc.
4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon